These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17275988)

  • 21. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Jonasch E; Merchant MM; Spiess PE; Wood CG
    Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: Günter Janetschek. Laparoscopic partial nephrectomy for RCC: how can we avoid ischemic damage of the renal parenchyma? Eur Urol 2007;52:1303-5.
    Simone G; Guaglianone S; Gallucci M
    Eur Urol; 2008 Jun; 53(6):1302-3; author reply 1303-4. PubMed ID: 18222605
    [No Abstract]   [Full Text] [Related]  

  • 28. Open surgical management of renal cell carcinoma in the era of minimally invasive kidney surgery.
    Dave DS; Lam JS; Leppert JT; Belldegrun AS
    BJU Int; 2005 Dec; 96(9):1268-74. PubMed ID: 16287443
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytoreductive nephrectomy for metastatic renal cell carcinoma.
    McKiernan J; Wood CG
    J Urol; 2013 Aug; 190(2):386-8. PubMed ID: 23702308
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphatic spread in renal cell carcinoma: have retroperitoneal lymph node dissection a therapeutic advantage?
    Gilloz A; Lévigne F; Héritier P; Perraud Y; el Hajj E; Diez-Yanguas J
    Prog Clin Biol Res; 1989; 303():729-30. PubMed ID: 2780669
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Outcomes following partial nephrectomy by tumor size P. L. Crispen, S. A. Boorjian, C. M. Lohse, T. S. Sebo, J. C. Cheville, M. L. Blute and B. C. Leibovich J Urol 2008; 180: 1912-1917.
    Cimen HI; Serefoglu EC; Balbay MD
    J Urol; 2009 Sep; 182(3):1232; author reply 1232. PubMed ID: 19625039
    [No Abstract]   [Full Text] [Related]  

  • 32. Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy.
    Russo P; O'Brien MF
    Urol Clin North Am; 2008 Nov; 35(4):679-86; viii. PubMed ID: 18992621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    J Urol; 2008 Jul; 180(1):99-103; discussion 103. PubMed ID: 18485415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma.
    Chapman TN; Sharma S; Zhang S; Wong MK; Kim HL
    Urology; 2008 Feb; 71(2):287-91. PubMed ID: 18308105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current aspects in the therapy of renal cell cancer].
    Heynemann H
    Praxis (Bern 1994); 2008 Apr; 97(8):427-30. PubMed ID: 18551912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Carcinoma of the Bellini collecting duct in paediatric patients: a case report and review of the literature].
    Gurrera A; Amico P; Di Cataldo A; Vasquez E; Magro G
    Pathologica; 2007 Oct; 99(5):301-5. PubMed ID: 18354951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presurgical therapy in metastatic renal cell carcinoma.
    Jonasch E
    Expert Rev Anticancer Ther; 2007 Jan; 7(1):73-8. PubMed ID: 17187521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor size and nephron-sparing surgery: does it still matter?
    Bensalah K; Crépel M; Patard JJ
    Eur Urol; 2008 Apr; 53(4):691-3. PubMed ID: 18060683
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of lung and lymphnode metastasis treated with carbon ion radiotherapy after radical nephrectomy for renal cell carcinoma].
    Nakao A; Takiuchi H
    Hinyokika Kiyo; 2008 May; 54(5):345-7. PubMed ID: 18546858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.